Polylactic acid based polymeric nanoparticle mediated co-delivery of navitoclax and decitabine for cancer therapy

被引：12
作者：
Mehrotra, Neha [1 ]
Anees, Mohd [1 ]
Tiwari, Sachchidanand [1 ]
Kharbanda, Surender [2 ]
Singh, Harpal [1 ,3 ]
机构：
[1] Indian Inst Technol Delhi, Ctr Biomed Engn, New Delhi, India
[2] Hillstream Biopharm Inc, Bridgewater Township, NJ USA
[3] All India Inst Med Sci Delhi, Dept Biomed Engn, New Delhi, India
来源：
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2023年 / 47卷
关键词：
Combination nanomedicine; cancer therapy; Navitoclax; Decitabine; Breast cancer; AML; BCL-2; FAMILY; IN-VITRO; ABT-263; 5-AZA-2'-DEOXYCYTIDINE; RESISTANCE; INHIBITORS; TUMORS;
D O I：
10.1016/j.nano.2022.102627
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
Combination chemotherapy with systemic administration of drugs in their free form can be challenging due to non-synchronized phar-macokinetics and sub-optimal tumor accumulation. The present study investigates a PLA-based block copolymeric nanocarrier for the co -delivery of navitoclax and decitabine (NAV/DCB NPs) for combination cancer therapy. NAV/DCB NPs exhibited potent in vitro synergistic cytotoxicity in both acute myeloid leukemia and breast cancer cell lines. Biodistribution studies of NAV/DCB NPs in tumor bearing mice, showed significant drug accumulation in tumor tissue and detectable quantities in plasma even after 48 h. Good hemocompatibility with reduced in vivo platelet toxicity indicated that encapsulation in PLA-based nanocarrier helped ameliorate navitoclax associated thrombo-cytopenia. In vivo biological activity of NAV/DCB NPs evaluated in xenograft AML and syngeneic breast cancer model, demonstrated potent tumor growth inhibition efficacy. PLA-based NAV/DCB dual NPs present a novel, safe and effective nanoformulation for combination cancer therapy in both solid tumors and hematologic malignancies.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页数：13
相关论文
共 39 条
[1]   Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent [J].
Anuar, Nur Najmi Mohamad ;
Hisam, Nur Syahidah Nor ;
Liew, Sze Ling ;
Ugusman, Azizah .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[2]   Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness [J].
Barnestein, Robby ;
Galland, Loick ;
Kalfeist, Laura ;
Ghiringhelli, Francois ;
Ladoire, Sylvain ;
Limagne, Emeric .
ONCOIMMUNOLOGY, 2022, 11 (01)
[3]   BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies [J].
Bogenberger, J. M. ;
Kornblau, S. M. ;
Pierceall, W. E. ;
Lena, R. ;
Chow, D. ;
Shi, C-X ;
Mantei, J. ;
Ahmann, G. ;
Gonzales, I. M. ;
Choudhary, A. ;
Valdez, R. ;
Camoriano, J. ;
Fauble, V. ;
Tiedemann, R. E. ;
Qiu, Y. H. ;
Coombes, K. R. ;
Cardone, M. ;
Braggio, E. ;
Yin, H. ;
Azorsa, D. O. ;
Mesa, R. A. ;
Stewart, A. K. ;
Tibes, R. .
LEUKEMIA, 2014, 28 (08) :1657-1665
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[5]   KINETICS OF DEAMINATION OF 5-AZA-2'-DEOXYCYTIDINE AND CYTOSINE-ARABINOSIDE BY HUMAN-LIVER CYTIDINE DEAMINASE AND ITS INHIBITION BY 3-DEAZAURIDINE, THYMIDINE OR URACIL ARABINOSIDE [J].
CHABOT, GG ;
BOUCHARD, J ;
MOMPARLER, RL .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (07) :1327-1328
[6]   Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment [J].
Chakraborty, Kasturee ;
Tripathi, Archana ;
Mishra, Sukumar ;
Mallick, Argha Mario ;
Roy, Rituparna Sinha .
BIOSCIENCE REPORTS, 2022, 42 (07)
[7]   The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo [J].
Chen, Jun ;
Jin, Sha ;
Abraham, Vivek ;
Huang, Xiaoli ;
Liu, Bernard ;
Mitten, Michael J. ;
Nimmer, Paul ;
Lin, Xiaoyu ;
Smith, Morey ;
Shen, Yu ;
Shoemaker, Alexander R. ;
Tahir, Stephen K. ;
Zhang, Haichao ;
Ackler, Scott L. ;
Rosenberg, Saul H. ;
Maecker, Heather ;
Sampath, Deepak ;
Leverson, Joel D. ;
Tse, Chris ;
Elmore, Steven W. .
MOLECULAR CANCER THERAPEUTICS, 2011, 10 (12) :2340-2349
[8]   Synthesis and properties of poly(L-lactide)-poly (ethylene glycol) multiblock copolymers by coupling triblock copolymers [J].
Chen, WN ;
Luo, WJ ;
Wang, SG ;
Bei, JZ .
POLYMERS FOR ADVANCED TECHNOLOGIES, 2003, 14 (3-5) :245-253
[9]   Poly(lactic acid)/Poly(ethylene glycol) Polymer Nanocomposites: Effects of Graphene Nanoplatelets [J].
Chieng, Buong Woei ;
Ibrahim, Nor Azowa ;
Yunus, Wan Md Zin Wan ;
Hussein, Mohd Zobir .
POLYMERS, 2014, 6 (01) :93-104
[10]   Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors [J].
Cowan, Lisa A. ;
Talwar, Sundeep ;
Yang, Allen S. .
EPIGENOMICS, 2010, 2 (01) :71-86
1234